Trichomonas vaginalis and HIV: a narrative review
DOI:
https://doi.org/10.55892/jrg.v8i19.2270Keywords:
Trichomonas vaginalis. HIV. Women. STI. Coinfection.Abstract
Introduction: Trichomonas vaginalis is a protozoan parasite responsible for trichomoniasis, a common asymptomatic sexually transmitted infection (STI), which is associated with complications such as vaginal inflammation and an increased susceptibility to HIV infection. Tissue damage and the local immune response may facilitate viral entry. This study aims to examine the association between trichomoniasis and HIV, as well as its implications for public health. Methodology: A narrative literature review was conducted through searches in the MEDLINE and LILACS databases. The selection criteria included open-access articles published within the past five years, using the DECS descriptors “Trichomonas vaginalis,” “HIV,” and “Women.” Results: The literature indicates that co-infection with Trichomonas vaginalis and HIV enhances viral transmission and disease progression due to factors such as genital inflammation, mucosal disruption, and alterations in the genital microbiota. Additionally, asymptomatic male carriers serve as vectors, while adolescents and pregnant women constitute particularly vulnerable populations. Mechanisms including elevated viral load and the modulatory role of galectins further intensify the risk. Consequently, early detection and treatment are essential to reduce complications and transmission rates. Conclusion: Infection with Trichomonas vaginalis significantly increases the risk of acquiring and transmitting HIV. Therefore, its management should be incorporated into comprehensive STI control strategies, including prevention, early diagnosis, and treatment, with a particular emphasis on at-risk populations.
Downloads
References
ALSAAD, R. K. A. Past, present and future of Trichomonas vaginalis: A review study. Annals of Parasitology, v. 68, n. 3, 2022. Disponível em: https://annals-parasitology.eu/archive_2001_2022/2022-68-3_409.pdf . Acesso em: 10 mai. 2025.
BEESHAM, I. M. et al. Sexually Transmitted Infection Prevalence, Partner Notification, and Human Immunodeficiency Virus Risk Perception in a Cohort of Women Completing Sexually Transmitted Infection Screening as Part of a Safer Conception Study. Jounal of the American Sexually Transmitted Diseases Association, 2024. Disponível em: https://wiredspace.wits.ac.za/server/api/core/bitstreams/6e76c941-1ce4-4599-9ed6-a427d8358c27/content. Acesso em: 10 mai. 2025.
BRASIL. Ministério da Saúde. Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas com Infecções Sexualmente Transmissíveis – IST / Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. – Brasília : Ministério da Saúde, 2022. 211 p. Disponível em: https://www.gov.br/aids/pt-br/central-de-conteudo/pcdts/2022/ist/pcdt-ist-2022_isbn-1.pdf/view. Acesso em: 12 mar. 2025.
DAUBERT, E. M. et al. Declining Prevalence of Trichomonas vaginalis Diagnosed by Wet Mount in a Cohort of U.S. Women With and Without HIV. Journal of Women’s Health, v. 33, n. 3, p. 388–395, 1 mar. 2024. Disponível em: https://www.liebertpub.com/doi/full/10.1089/jwh.2023.0263. Acesso em: 10 mai. 2025.
DUARTE, G. et al. Vulvovaginitis in pregnant women. Revista Brasileira Ginecologia e Obstetrícia, v. 46, 1 jan. 2024. Disponível em: journalrbgo.org/article/vulvovaginitis-in .Acesso em: 12 mai. 2025.
FICHOROVA, R. N. et al. Protozoan-Viral-Bacterial Co-Infections Alter Galectin Levels and Associated Immunity Mediators in the Female Genital Tract. Frontiers in Cellular and Infection Microbiology, v. 11, 5 ago. 2021. Disponível em: https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2021.649940/full . Acesso em: 12 mai. 2025.
FORTAS, C. et al. Asymptomatic infections with Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis among women in low- and middle-income countries: A systematic review and meta-analysis. PLOS global public health, v. 4, n. 5, p. e0003226–e0003226, 23 maio 2024. Disponível em: https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0003226 . Acesso em: 21 mar. 2025.
HUNIDZARIRA, P. et al. Population-Level Correlation Between Incidence of Curable Sexually Transmitted Infections and Human Immunodeficiency Virus (HIV)-1 Among African Women Participating in HIV-1 Pre-Exposure Prophylaxis Trials. The Journal of Infectious Diseases, v. 226, n. 6, p. 1069–1074, 28 jun. 2022. Disponível em: https://academic.oup.com/jid/article/226/6/1069/6619245 .Acesso em: 10 mai. 2025.
KISSINGER, P. J. et al. Diagnosis and management of trichomonas vaginalis: Summary of evidence reviewed for the 2021 Centers for Disease Control and Prevention sexually transmitted infections treatment guidelines. Clinical Infectious Diseases, v. 74, n. Supplement_2, p. S152–S161, 13 abr. 2022. Disponível em: https://academic.oup.com/cid/article/74/Supplement_2/S152/6567967?login=false#google_vignette. Acesso em: 25 mai. 2025.
LAZENBY, G. B. MD. et al. Diagnosis, Treatment, Follow-up, and Persistence of Trichomonas vaginalis in Women 45 Years and Older According to HIV Status: A 10-Year Retrospective Cohort. Jounal of the American Sexually Transmitted Diseases Association, 2020. Disponível em: https://journals.lww.com/stdjournal/abstract/2020/05000/diagnosis,_treatment,_follow_up,_and_persistence.10.aspx . Acesso em: 10 mai. 2025.
LOBATO, M. J. et al. Características da infecção sexualmente transmissível (IST) causada por Trichomonas vaginalis: revisão bibliográfica. Brazilian Journal of Health Review, v. 7, n. 1, p. 1864–1881, 23 jan. 2024. Disponível em: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/66507/47432. Acesso em: 21 mar. 2025.
LUJAN, A. L. et al. Galectins as potential therapeutic targets in STIs in the female genital tract. Nature Reviews Urology, v. 19, n. 4, p. 240–252, 1 abr. 2022. Disponível em: https://www.researchgate.net/publication/358272971_Galectins_as_potential_therapeutic_targets_in_STIs_in_the_female_genital_tract . Acesso em: 12 mai. 2025.
MABASO, N.; ABBAI, N. S. A review on Trichomonas vaginalis infections in women from Africa. Southern African Journal of Infectious Diseases, v. 36, n. 1, 10 jun. 2021. Disponível em: https://sajid.co.za/index.php/sajid/article/view/254 . Acesso em: 10 mai. 2025.
MAUEIA, C. et al. The relationship between selected sexually transmitted pathogens, HPV and HIV infection status in women presenting with gynaecological symptoms in Maputo City, Mozambique. PLoS ONE, v. 19, n. 9, p. e0307781–e0307781, 6 set. 2024. Disponível em: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0307781. Acesso em: 12 mai. 2025.
MASHA, S. C. et al. Trichomonas vaginalis and HIV infection acquisition: a systematic review and meta-analysis. Sexually Transmitted Infections, v. 95 p. 36-42, 2019. Disponível em: https://sti.bmj.com/content/95/1/36. Acesso em: 19 mai. 2025.
MKHIZE, P. et al. Differences in HIV risk factors between South African adolescents and adult women and their association with sexually transmitted infections. Sexually Transmitted Infections, p. sextrans-056260, 4 dez. 2024. Disponível em: https://sti.bmj.com/content/101/3/174. Acesso em: 10 mai. 2025.
NYEMBA, D. C. et al. The effect of STI screening during pregnancy on vertical transmission of HIV and adverse pregnancy outcomes in South Africa: a modelling study. Journal of the International AIDS Society, v. 28, n. 2, 26 jan. 2025. Disponível em: https://onlinelibrary.wiley.com/doi/10.1002/jia2.26410. Acesso em: 5 mai. 2025.
PASCOAL, L. I. et al. Trichomonas vaginalis como Co-Fator na propagação do HIV em mulheres: uma revisão de literatura/ Trichomonas vaginalis as a Co-Factor in HIV propagation in women: a review of the literature.Brazilian Journal of Development, v. 7, n. 5, p. 52660–52673, 26 maio 2021. Disponível em: https://ojs.brazilianjournals.com.br/ojs/index.php/BRJD/article/download/30413/23937/77887. Acesso em: 19 mai. 2025.
PETERS, R. P. et al. Mother-to-child transmission of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in HIV-infected pregnant women in South Africa. International journal of STD & AIDS, v. 32, n. 9, p. 799–805, 1 ago. 2021. Disponível em: https://journals.sagepub.com/doi/abs/10.1177/0956462421990218. Acesso em: 5 mai. 2025.
QULU, W. et al. High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV. PloS one, v. 18, n. 11, p. e0294698, 30 nov. 2023. Disponível em: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0294698. Acesso em: 12 mai. 2025.
RAFFONE, A. et al. Gardnerella vaginalis and Trichomonas vaginalis infections as risk factors for persistence and progression of low-grade precancerous cervical lesions in HIV-1 positive women. Pathology - Research and Practice, v. 219, p. 153349, mar. 2021. Disponível em: https://www.iris.unina.it/retrieve/e268a731-e148-4c8f-e053-1705fe0a812c/56.%20CIN-SIL%20GV%20%26%20TV.pdf . Acesso em: 15 mai. 2025.
SCHUETTFORT, G. et al. Sexually transmitted diseases in people living with HIV after implementation of cost coverage of HIV pre‐exposure prophylaxis by statutory health insurance in Germany. HIV Medicine, v. 24, n. 2, p. 163–169, 20 jul. 2022. Disponível em: https://onlinelibrary.wiley.com/doi/10.1111/hiv.13353 .Acesso em: 10 mai. 2025.
SCHUMANN, A. J, PLASNER, S. Trichomoniasis. PMC, p. 00-01, 12 jun. 2023.
Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK534826/. Acesso em: 16 mai. 2025.
SILVA, A. et al. The relationship between HIV status and clinical manifestations of urogenital infections in women during pregnancy: a scoping review. DST, v. 35, 1 jan. 2023. Disponível em: https://www.bjstd.org/revista/article/view/1384/1457 . Acesso em: 6 mai. 2025.
SWINKELS, H. M, NGUYEN, A.D, GULICK, P. G. HIV and AIDS Syndrome. StatPearls Publishing; 2024. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK534860/ . Acesso em: 19 mai. 2025.
TAKU, O. et al. Detection of sexually transmitted pathogens and co-infection with human papillomavirus in women residing in rural Eastern Cape, South Africa. PeerJ, v. 9, p. e10793, 3 mar. 2021. Disponível em: https://peerj.com/articles/10793/. Acesso em: 5 mai. 2025.
VOUX, A. DE et al. Point-of-care testing for sexually transmitted infections and HIV pre-exposure prophylaxis among pregnant women in South Africa, 2021–2022: randomised controlled trial. Sexually Transmitted Infections, v. 100, n. 2, p. 77–83, 1 mar. 2024. Disponível em: https://www.researchgate.net/publication/376582975_Point-of-care_testing_for_sexually_transmitted_infections_and_HIV_pre-exposure_prophylaxis_among_pregnant_women_in_South_Africa_2021-2022_randomised_controlled_trial. Acesso em: 15 mai. 2025
WORLD HEALTH ORGANIZATION. HIV and AIDS. 2024. Disponível em: <https://www.who.int/news-room/fact-sheets/detail/hiv-aids>. Acesso em: 3 mai. 2025
ZHANG, Q. et al. High rates of Treponema pallidum, Neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis co-infection in people with HIV: a systematic review and meta-analysis. European Journal of Clinical Microbiology & Infectious Diseases, 28 out. 2024. . Disponível em: https://link.springer.com/article/10.1007/s10096-024-04966-w. Acesso em: 5 mai. 2025